Aspire BioPharma, Inc. Working Capital to Net Assets Ratio
Aspire BioPharma, Inc. working capital to net assets ratio. Aspire BioPharma, Inc. (ASBP) has a Working Capital to Net Assets ratio of 100.2% as of June 2026. Working capital of $11.78 Million (current assets of $13.47 Million minus current liabilities of $1.69 Million) is measured against net assets of $11.76 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Aspire BioPharma, Inc. (ASBP) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Aspire BioPharma, Inc. (2021–2025)
Working capital to net assets ratio of Aspire BioPharma, Inc. from 2021 to 2025. This chart shows how Aspire BioPharma, Inc.'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 100.2%, reflecting working capital of $11.78 Million against net assets of $11.76 Million USD. See Aspire BioPharma, Inc. (ASBP) defensive interval to measure how many days the company can operate on defensive assets alone.
Aspire BioPharma, Inc. Working Capital to Net Assets Ratio by Year (2021–2025)
Aspire BioPharma, Inc. working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Aspire BioPharma, Inc. from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Aspire BioPharma, Inc.'s balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 98.5% | $-6.28 Million | $-6.38 Million | $1.31 Million | $7.59 Million | ▼ -1.5 pp |
| 2024 | 100.0% | $-1.54 Million | $-1.54 Million | $147.99K | $1.69 Million | ▲ +101.6 pp |
| 2023 | -1.6% | $-322.11K | $19.58 Million | $81.22K | $403.33K | ▼ -1.9 pp |
| 2022 | 0.3% | $794.43K | $289.07 Million | $1.10 Million | $303.32K | ▼ -99.7 pp |
| 2021 | 100.0% | $-475.00 | $-475.00 | $293.22K | $293.70K | — |